| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 20830-75-5 | 地高辛; 狄高辛; 狄戈辛; 地谷新; 毛地黃葉毒苷; 異羥基洋地黃毒苷原; 長葉毛地黃苷; 地辛高 | digoxin; Digitoxin,12b-hydroxy- (6CI); Digoxin (8CI); 12b-Hydroxydigitoxin; Cardigox; Cardiogoxin; Cardioxin; Cardixin; Cardoxin; Chloroformic digitalin; Coragoxine; Cordioxil; Davoxin; Digacin; Digicor; Digomal; Digon; Digosin; Digoxin Nativelle; Digoxine; Dilanacin; Dixina; Dokim; Dynamos; Eudigox; Fargoxin; GREXIN; Homolle's digitalin; Lanacordin; Lanacrist; Lanicor; Lanikor; Lanocardin; Lanorale; Lanoxicaps; Lanoxin; Lanoxin PG; Lenoxicaps; Lenoxin; Longdigox; Mapluxin; NSC 95100; Natigoxin; NeoDioxanin; Novodigal-Amp.; Purgoxin; Rougoxin; Stillacor; Toloxin; Vanoxin |  | C41H64O14 | 詳情 | 供應(yīng)商 |
| 17032-39-2 | Ethanaminium,N,N,N-trimethyl-2-(phosphonooxy)-, chloride, magnesium salt (1:1:1); Choline,chloride, dihydrogen phosphate, magnesium salt (1:1) (8CI); HepaREXINe; Magnesium phosphorylcholine chloride; Phosphorylcholine magnesium salt |  | C5H13ClMgNO4P | 詳情 | 供應(yīng)商 | |
| 1740-22-3 | 吡諾林; 吡諾林; | 2-Pyridinemethanol, a-[3-(di-2-pyridinylmethylene)-2,4-cyclopentadien-1-yl]-a-2-pyridinyl-; 1,4-Cyclopentadiene-1-methanol,3-(di-2-pyridylmethylene)-a,a-di-2-pyridyl- (7CI,8CI); 2-Pyridinemethanol, a-[3-(di-2-pyridinylmethylene)-1,4-cyclopentadien-1-yl]-a-2-pyridinyl- (9CI); 3-(Di-2-pyridylmethylene)-a,a-di-2-pyridyl-1,4-cyclopentadiene-1-methanol; Di-2-pyridyl(6,6-di-2-pyridyl-2-fulvenyl)-methanol; McN 1210; Pyrinoline; SuREXIN; a,a,6,6-Tetra-(2-pyridyl)-2-fulvenemethanol |  | C27H20N4O | 詳情 | 供應(yīng)商 |
| 129024-87-9 | 4,7,10,13,16,19-Docosahexaenamide,N-[2-(3,4-dihydroxyphenyl)ethyl]-, (4Z,7Z,10Z,13Z,16Z,19Z)-; 4,7,10,13,16,19-Docosahexaenamide,N-[2-(3,4-dihydroxyphenyl)ethyl]-, (all-Z)-; DopREXIN; NMI 8739 |  | C30H41NO3 | 詳情 | 供應(yīng)商 | |
| 532932-99-3 | ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-IL | (ALA11,D-LEU15)-OREXIN B (HUMAN); ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2; H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2; [ALA11,D-LEU15]-OREXIN B; (ALA11,D-LEU15)-OREXIN B (HUMAN); H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2; M.W. 2857.28 C120H206N44O35S |  | C120H206N44O35S | 詳情 | 供應(yīng)商 |
| 205640-91-1 | 食欲肽B (人) | OREXIN B (HUMAN); ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2; HYPOCRETIN-2; HYPOCRETIN-2, HUMAN; H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2; RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2; OREXINS OREXIN B HUMAN; OREXIN B (HUMAN); H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 |  | C123H212N44O35S | 詳情 | 供應(yīng)商 |
| 205640-90-0 | OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT) | PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-; HYPOCRETIN; PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-LEU-NH2; PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-LEU-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); OREXINS OREXIN A HUMAN, RAT, MOUSE; OREXIN A, BOVINE, HUMAN, MOUSE, RAT |  | C152H247N47O44S4 | 詳情 | 供應(yīng)商 |